|
"fang yj"的相關文件
顯示項目 11-19 / 19 (共1頁)
1
每頁顯示[10|25|50]項目
| 中山醫學大學 |
2021 |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu, CH; Chen, PY; Chen, JJ; Lo, CC; Su, WW; Tseng, KC; Liu, CJ; Huang, CS; Huang, KJ; Yang, SS; Peng, CY; Tsai, MC; Kao, WY; Chang, CY; Shih, YL; Fang, YJ; Chen, CY; Lee, PL; Huang, JJ; Su, PY; Tseng, CW; Hung, CC; Chang, CH; Huang, YJ; Lai, HC; Chang, CC; Lee, FJ; Hsieh, TY; Kao, JH |
| 中山醫學大學 |
2021 |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu, CH; Chen, CY; Su, WW; Tseng, KC; Lo, CC; Liu, CJ; Chen, JJ; Peng, CY; Shih, YL; Yang, SS; Huang, CS; Huang, KJ; Chang, CY; Tsai, MC; Kao, WY; Fang, YJ; Chen, PY; Su, PY; Tseng, CW; Huang, JJ; Lee, PL; Lai, HC; Hsieh, TY; Chang, CH; Huang, YJ; Lee, FJ; Chang, CC; Kao, JH |
| 國家衛生研究院 |
2020-11 |
Effects of urate-lowering therapy on risk of hyperlipidemia in gout by a population-based cohort study and on in vitro hepatic lipogenesis-related gene expression
|
Fang, YJ;Wu, TY;Lin, CL;Su, CY;Li, JR;Chung, YL;Tien, N;Lim, YP |
| 國家衛生研究院 |
2020-07 |
Association between gout, urate-lowering therapy, and risk of developing type 2 diabetes mellitus: A nationwide population-based retrospective cohort study
|
Fang, YJ;Chung, YL;Lin, CL;Lim, YP |
| 中山醫學大學 |
2020 |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu, CH; Peng, CY; Fang, YJ; Kao, WY; Yang, SS; Lin, CK; Lai, HC; Su, WP; Fang, SU; Chang, CC; Su, TH; Liu, CJ; Chen, PJ; Chen, DS; Kao, JH |
| 臺大學術典藏 |
2019-09-26T07:12:40Z |
Taurine ameliorates alcoholic steatohepatitis via enhancing self-antioxidant capacity and alcohol metabolism
|
Chen, YC;MING-FONG CHEN;Lin, HW;CHUNG-HSI CHOU;Chang, YY;Chiu, CH;Fang, YJ; Fang, YJ; Chiu, CH; Chang, YY; CHUNG-HSI CHOU; Lin, HW; MING-FONG CHEN; Chen, YC |
| 中國醫藥大學 |
2014-03 |
A double-blind randomized controlled study to evaluate the efficacy of low-dose oral interferon-alpha in preventing hepatitis C relapse
|
(Lee CM);(Chen CY);(Chien RN);(Tseng KC);彭成元(Cheng-Yuan Peng);(Tung SY);(Fang YJ);(Huang YH);(Lu SN);(Hung CH);(Tsai TJ);(Fang CC);(Hsu CW);(Yeh CT)* |
| 臺北醫學大學 |
2014 |
Evaluation of Abdominal Ultrasonography Mass Screening for Hepatocellular Carcinoma in Taiwan
|
Yeh, YP;Hu, TH;Cho, PY;Chen, HH;AMF, Yen;SLS, Chen;SYH, Chiu;JCY, Fann;Su, WW;Fang, YJ;Chen, ST;San, HC;Chen, HP;CS*, Liao |
| 臺北醫學大學 |
2013 |
Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan
|
Yeh, YP;Hu, TH;Cho, PY;Chen, HH;Yen, AM;Chen, LS;Chiu, SY;Fann, JC;Su, WW;Fang, YJ;Chen, ST;San, HC;Chen, HP;Liao, CS;Community?bas, Changhua |
顯示項目 11-19 / 19 (共1頁)
1
每頁顯示[10|25|50]項目
|
